| Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
| Veids | Finanšu pārskati |
| Valoda | EN |
| Statuss | Publicēts |
| Versija | |
| Datums | 2014-03-11 15:50:48 |
| Periods | |
| Versijas komentārs | |
| Teksts |
Olainfarm Holds Fourth Quarter 2013 Investor Conference Webinar AS „Olainfarm” invites shareholders, investors, mass media representatives and other stakeholders to join its fourth quarter 2013 investor conference webinar scheduled on March 11, 2014 at 16:00 (EET). Webinar will be hosted by the member of the management board Salvis Lapiņš. The presentation will be in English. During the webinar topics in relation to AS “Olainfarm” latest activities and analysis of fourth quarter 2013 financial results will be discussed.
What is webinar?
How to join the webinar?
Additional information on the webinar The enclosed presentation will be presented during the webinar.
A/s OlainFarm is one of the biggest pharmaceutical companies in Latvia with 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 30 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information
prepared by:
|
| Pielikumi |